Medicaments containing shikonin compounds and salts thereof including shikonin and alkannin are used for treatment of virus infections, mycoplasma infections and malignant tumor. In operation, a carbon-containing precursor is introduced to the chamber to contact the catalyst with a sufficient amount of heat to cause the deposition of carbon on the catalyst. The combination vaccine as described herein comprises at least one M. The object is displayed on the map in accordance with the translated first position information.